Adven Biotech: Pioneering Global Standards in Homeopathy with NABL Certification

Adven Biotech has achieved a significant milestone by becoming the first homeopathy brand in India to receive accreditation from the National Accreditation Board for Testing and Calibration Laboratories (NABL). This recognition positions the company at the forefront of India's push to enhance the credibility and quality of the Ayush healthcare sector on a global scale.

The NABL certification aligns with Prime Minister Narendra Modi's vision of promoting Ayush as a globally trusted healthcare system. The certification sets new standards for transparency, accuracy, and credibility in the homeopathic medicine manufacturing sector, areas where quality assurance has traditionally been a concern.

Speaking about the achievement, Adesh Sharma, CEO of Adven Biotech, emphasized the responsibility that comes with this recognition, highlighting that it enhances confidence among both doctors and patients. With this accreditation, Adven aims to expand the global reach of its homeopathic products, ensuring they're validated through globally accepted protocols, leading to consistent and reliable outcomes for patients everywhere.